Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

NHS approves InterCure hypertension treatment device

InterCure has received NHS stamp for its non-drug, non-invasive hypertension treatment device, RESPeRATE.

RESPeRATE, a respiratory modulator used by patients for just 15 minutes a day, at least four times a week, is proven to lower the blood pressure (BP).

RESPeRATE was approved after a six-month review of its ten supporting clinical studies (five of which were randomised, controlled), patient satisfaction analyses and cost-benefit economic models.

InterCure said its RESPeRATE has also met all of the Department of Health’s (DoH) requirements for safety, quality, appropriateness and cost effectiveness.

InterCure CSO and RESPeRATE inventor Benjamin Gavish said they are delighted that patients in the UK can now obtain RESPeRATE on prescription.

"We hope that this move by the NHS to set up a new device category to supplement the currently available treatment options for hypertension will encourage GPs to integrate RESPeRATE into their hypertension standard of care," Gavish said.